» Articles » PMID: 30538791

Predictive and Individualized Management of Stroke-success Story in Czech Republic

Overview
Journal EPMA J
Date 2018 Dec 13
PMID 30538791
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The model of centralized stroke care in the Czech Republic was created in 2010-2012 by Ministry of Health (MH) in cooperation with professional organization-Cerebrovascular Section of the Czech Neurological Society (CSCNS). It defines priorities of stroke care, stroke centers, triage of suspected stroke patients, stroke care quality indicators, their monitoring, and reporting. Thirteen complex cerebrovascular centers (CCC) provide sophisticated stroke care, including intravenous thrombolysis (IVT), mechanical thrombectomy (MTE), as well as other endovascular (stenting, coiling) and neurosurgical procedures. Thirty-two stroke centers (SC) provide stroke care except endovascular procedures and neurosurgery. The triage is managed by emergency medical service (EMS). The most important quality indicators of stroke care are number of hospitalized stroke patients, number of IVT, number of MTE, stenting and coiling, number of neurosurgical procedures, and percentage of deaths within 30 days. Indicators provided into the register of stroke care quality (RES-Q) managed by CSCNS are time from stroke onset to hospital admission, door-to-needle time, door-to-groin time, type of ischemic stroke, and others. Data from RES-Q are shared to all centers. Within the last 5 years, the Czech Republic becomes one of the leading countries in acute stroke care. The model of centralized stroke care is highly beneficial and effective. The quality indicators serve as tool of control of stroke centers activities. The sharing of quality indicators is useful tool for mutual competition and feedback control in each center. This comprehensive system ensures high standard of stroke care. This system respects the substantial principles of personalized medicine-individualized treatment of acute stroke and other comorbidities at the acute disease stage; optimal prevention, diagnosis and treatment of possible complications; prediction of further treatment and outcome; individualized secondary prevention, exactly according to the stroke etiology. The described model of stroke care optimally meets criteria of predictive, preventive, and personalized medicine (PPPM), and could be used in other countries as well with the aim of improving stroke care quality in general.

Citing Articles

Utilization, Workflow, and Outcomes of Endovascular Thrombectomy in Patients With vs Without Premorbid Disability in a National Registry.

Ganesh A, Volny O, Kovacova I, Tomek A, Bar M, Padr R Neurol Clin Pract. 2024; 14(6):e200341.

PMID: 39185095 PMC: 11341008. DOI: 10.1212/CPJ.0000000000200341.


Grace Under Pressure: Resiliency of Quality Monitoring of Stroke Care During the Covid-19 Pandemic in Mexico City.

Medina-Rioja R, Gonzalez-Calderon G, Saldivar-Davila S, Estrada Saul A, Gayon-Lombardo E, Somerville-Briones N Front Neurol. 2022; 13:831735.

PMID: 35463140 PMC: 9020365. DOI: 10.3389/fneur.2022.831735.


Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Reddy V, Grogan D, Ahluwalia M, Lopes Salles E, Ahluwalia P, Khodadadi H EPMA J. 2020; 11(2):217-250.

PMID: 32549916 PMC: 7272537. DOI: 10.1007/s13167-020-00203-4.


Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach.

Polivka Jr J, Polivka J, Pesta M, Rohan V, Celedova L, Mahajani S EPMA J. 2019; 10(1):81-99.

PMID: 30984317 PMC: 6459458. DOI: 10.1007/s13167-019-00162-5.

References
1.
Brunner-La Rocca H, Fleischhacker L, Golubnitschaja O, Heemskerk F, Helms T, Hoedemakers T . Challenges in personalised management of chronic diseases-heart failure as prominent example to advance the care process. EPMA J. 2016; 7:2. PMC: 4765020. DOI: 10.1186/s13167-016-0051-9. View

2.
Golubnitschaja O, Costigliola V . General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine. EPMA J. 2012; 3(1):14. PMC: 3485619. DOI: 10.1186/1878-5085-3-14. View

3.
Krebs W, Sharkey-Toppen T, Cheek F, Cortez E, Larrimore A, Keseg D . Prehospital Stroke Assessment for Large Vessel Occlusions: A Systematic Review. Prehosp Emerg Care. 2017; 22(2):180-188. DOI: 10.1080/10903127.2017.1371263. View

4.
Kernan W, Ovbiagele B, Black H, Bravata D, Chimowitz M, Ezekowitz M . Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45(7):2160-236. DOI: 10.1161/STR.0000000000000024. View

5.
Saver J, Goyal M, Bonafe A, Diener H, Levy E, Pereira V . Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA.... Int J Stroke. 2015; 10(3):439-48. PMC: 4405096. DOI: 10.1111/ijs.12459. View